BCAL Diagnostics Limited (ASX:BDX)
Australia flag Australia · Delayed Price · Currency is AUD
0.1200
0.00 (0.00%)
Feb 26, 2026, 1:47 PM AEST

BCAL Diagnostics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
4423391517-
Market Cap Growth
27.04%-41.31%164.34%-10.45%--
Enterprise Value
44173685-
Last Close Price
0.120.060.130.070.08-
PS Ratio
17.408.7012.905.3323.09-
PB Ratio
17.683.714.572.851.72-
P/TBV Ratio
17.683.724.602.851.72-
EV/Sales Ratio
17.456.5511.742.887.25-
Debt / Equity Ratio
1.380.380.180.20--
Net Debt / Equity Ratio
0.04-0.34-0.58-0.40-0.99-0.94
Net Debt / EBITDA Ratio
-0.020.340.860.453.163.68
Net Debt / FCF Ratio
-0.020.310.870.332.952.82
Asset Turnover
0.270.240.300.290.100.11
Quick Ratio
3.672.293.572.5910.917.15
Current Ratio
3.672.323.602.7411.007.86
Return on Equity (ROE)
-121.67%-97.79%-92.74%-68.16%-51.11%-75.39%
Return on Assets (ROA)
-46.59%-39.67%-36.82%-31.56%-25.88%-23.57%
Return on Capital Employed (ROCE)
-117.80%-103.50%-62.90%-78.30%-31.60%-25.90%
Earnings Yield
-16.21%-31.41%-16.29%-34.06%-20.40%-
FCF Yield
-14.62%-30.03%-14.44%-43.13%-19.55%-
Buyback Yield / Dilution
-14.40%-46.04%-16.75%-3.24%-51.65%-17.28%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.